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Purpose. To examine the eﬀects of transcorneal freezing using a new cryoprobe designed for corneal endothelial surgery.Methods.
A freezing console employing nitrous oxide as a cryogen was used to cool a series of diﬀerent cryoprobe tip designs made of silver
for high thermal conductivity. In vitro studies were conducted on 426 porcine corneas, followed by preliminary in vivo
investigations on three rabbit corneas. Results. The corneal epithelium was destroyed by transcorneal freezing, as expected;
however, the epithelial basement membrane remained intact. Reproducible endothelial damage was optimally achieved using a
3.4mm diameter cryoprobe with a concave tip proﬁle. Stromal edema was seen in the pre-Descemet’s area 24 hrs postfreeze
injury, but this had been resolved by 10 days postfreeze. A normal collagen ﬁbril structure was seen 1 month postfreeze,
concurrent with endothelial cell repopulation. Conclusions. Transcorneal freezing induces transient posterior stromal edema and
some residual deep stromal haze but leaves the epithelial basement membrane intact, which is likely to be important for corneal
re-epithelialization. Localized destruction of the endothelial monolayer was achieved in a consistent manner with a 3.4mm
diameter/concave proﬁle cryoprobe and represents a potentially useful approach to remove dysfunctional corneal endothelial
cells from corneas with endothelial dysfunction.
1. Introduction
Corneal transparency is maintained in the healthy eye by a
monolayer of endothelial cells on the inner surface of the
cornea. Even though human corneal endothelial cells do
not possess the capacity for proliferation in vivo, the endo-
thelium as a whole has a functional reserve to cope with cell
loss via the spreading and enlargement of cells adjacent to
those lost [1, 2]. Excessive endothelial loss and deterioration
caused by eye pathologies such as Fuchs’ endothelial corneal
dystrophy (FECD), however, lead to corneal edema, cloud-
ing, and eventually loss of vision. FECD is a progressive
degenerative disorder that is a major indication for corneal
transplant surgery. Surgical intervention in the form of a
full-thickness-penetrating keratoplasty—or more commonly
nowadays a posterior lamellar graft—is the main treatment
option. But, despite the success of corneal graft surgery, some
questions about the long-term survival of the donor tissue [3]
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and the recurring problem of suﬃcient tissue availability
remains. These limitations have led researchers to seek
potential alternatives to corneal transplantation to treat
corneal endothelial dysfunction.
One promising route involves the use of selective inhibi-
tors of the Rho kinase pathway. The so-called ROCK inhibi-
tors regulate the actin cytoskeleton and inﬂuence vital cell
activities such as motility, proliferation, and apoptosis [4].
Owing to their demonstrable value, numerous studies have
been conducted in recent years which focus on the eﬀect of
ROCK inhibitors on corneal endothelial cells both in vivo
and ex vivo [5–9]. One approach involves transcorneal freez-
ing to damage corneal endothelial cells in the central portion
of the cornea in patients with FECD followed by the topical
delivery of a ROCK inhibitor, Y27632, in the form of eye
drops to encourage peripheral endothelial cells that had been
unaﬀected by the freeze injury to repopulate the central zone
of the corneal endothelium [10–12]. Freeze damage is
achieved by application of a cold probe to the corneal surface.
Another approach involves cell injection therapy whereby
cultivated human corneal endothelial cells are injected into
the anterior chamber of the eyes with FECD in a suspension
that includes Y27632 ROCK inhibitor [13]. This agent has
also been tested in the form of eye drops as a long-term
pharmacological treatment for bullous keratopathy [14].
A small series of ﬁrst-in-man surgeries to test the concept
of transcorneal freezing followed by short-term ROCK inhib-
itor eye drop application for the treatment of FECD was
conducted a few years ago and showed promise [10–12]. In
this approach, the tip of a stainless steel rod, 2mm in diam-
eter, was immersed in liquid nitrogen at −196°C before being
applied to the surface of the central cornea for an arbitrarily
chosen time of 15 sec. The assumption was that central cor-
neal endothelial cells located underneath the cold-rod appli-
cator would be destroyed by freeze injury, although this could
not be directly conﬁrmed in the human subjects because the
cloudy FECD corneas did not allow a view of the endothe-
lium by specular microscopy. The freezing of corneal tissue
has also been used as a modality to induce an injury to facil-
itate basic research into corneal wound healing [15–28]. If
corneal freezing is to be used in a clinical setting, however,
(either for the destruction of diseased cells in the central
endothelium prior to ROCK inhibitor eye drop application
for FECD as described above or to pretreat the cornea prior
to targeted drug delivery to combat conditions such as fungal
keratitis) we contend that it needs to be achieved in a more
sophisticated, reliable, and reproducible manner than that
achieved with an immersion-cooled steel rod. Here, we
report the development and validation of a new cryoprobe
based on the expansion of nitrous oxide as a cryogen and
its eﬀect, in vitro and in vivo, on the corneal epithelium,
stroma, and endothelium.
2. Materials and Methods
2.1. Cryoprobe Development. A console that uses nitrous
oxide as a cryogen was manufactured in conjunction with a
series of cryoprobes with newly designed tips, some of which
matched the cornea’s curvature (Figure 1). This prototype
project was carried out by Coronet Medical Technologies
Ltd., the ophthalmic arm of Network Medical Products Ltd.
Enclosed gas expanded within the tip and was recycled
therein, achieving a low temperature based on the Joule/
Thomson eﬀect. The tip of the cryoprobe, used to contact
the corneal surface, was circular around the probe’s main axis
and a number of designs were tested. Probe tips were 1.8mm,
2.4mm, or 3.4mm in diameter and were manufactured from
silver for high thermal conductivity. Larger diameter probe
tips were not considered because of the option of multiple
surface freeze placements should a wider area of the cornea
need to be treated. Probes had either a ﬂat surface proﬁle or
a concave one with a radius of curvature of 8mm. For ease
of use, a foot switch was incorporated into the design, which
initiates cooling at the cryoprobe tip and maintains the
reduced temperature throughout the whole time it is
depressed. The foot switch is linked to a timer on the main
console that provides a visual output of freezing time plus
an audible signal (with a mute option) at 1 sec intervals when
the foot switch is depressed. Freezing temperature at the
probe tip (−50°C) is reached within 2 sec of depressing of
the foot switch; after release, ambient room temperature is
achieved within seconds. The hand-held cryoprobe has an
ergonomic-angled design to allow easy application to the
corneal surface (Figure 1). Probes should be thoroughly
cleaned, inspected, and autoclaved prior to use.
2.2. Transcorneal Freezing In Vitro. The porcine cornea is
comparable to that of the human cornea in terms of its
structure and its overall dimensions and the pig eye is
thus often used for practice by trainee corneal surgeons.
The central corneal thickness in adult pigs is usually
around 660μm [29, 30], which approximates a representa-
tive measurement of edematous corneal thickness in indi-
viduals with FECD [31, 32]. The porcine eyes, therefore,
were well suited for our investigations, and the intact
eyeballs, including extraocular muscles, were obtained
soon after slaughter at a local abattoir (W. T. Maddock,
Kembery Meats, Maesteg, Wales, UK). These were brought
to the laboratory on ice and experiments were begun
within 2-3 h of death. When the eyes arrived at the home
laboratory, ultrasound measurements of central corneal
thickness were made with a Tomey SP-100 pachymeter
(Erlangen, Germany), which revealed that the corneas
had thickened (~1000μm) postmortem compared to those
of published values [31, 32]. Consequently, the eyes were
placed in a humidiﬁed incubator (Brinsea Octagon 100,
Egg Incubator, Sandford, UK) at 45°C for 30–45min to
reverse the postmortem swelling and attain a thickness
similar to what might be expected in humans with FECD.
In total, 426 porcine eyes were used for the in vitro exper-
iments in which the corneal thickness ranged from 483μm
to 831μm owing to diﬀerences in eye size and likely
diﬀerential postmortem swelling and deswelling.
Immediately after an eye was removed from the humidi-
ﬁed incubator, its central corneal thickness was recorded as
an average of eight measurements. The cryoprobe tip was
then applied to the corneal surface and cooling was activated
by pressing the foot switch to control the ﬂow of nitrous
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oxide gas. Freezing times of 3, 5, 9, and 13 sec were tested,
allowing an additional 2 sec for the freezing temperature to
be reached in all cases (thus, a 3 sec freeze required for a
5 sec application and foot-switch depression). The cornea
was then carefully excised at the limbus after which stain-
ing solutions of 0.2% alizarin red (~1ml) and 0.25% try-
pan blue were applied sequentially to the endothelial
surface for 60–90 sec each to identify dead cells. The stains
were then gently washed oﬀ using approximately 5ml of
0.9% sodium chloride buﬀer solution, after which digital
images of the corneal endothelial surface were captured
on a Zeiss Stemi 1000 light microscope (Carl Zeiss, Jena,
Germany). A successful freeze injury was deemed to have
occurred when a clear circular wound area was seen. The
endothelial wound area in each corneal image was manually
traced and calculated using Image J software (http://imagej
.nih.gov/ij/). Magniﬁcation was calibrated for each set of
experiments using the image of an eyepiece graticule. Aver-
ages of three measurements were calculated and data were
further collated using Microsoft Excel software (Microsoft
Corp., Redmond, WA, USA).
2.3. Statistical Analysis. Statistical analyses were carried out
operating IBM SPSS Statistics software (Version 23.0, IBM
Corporation, New York, USA). Spearman’s rank order corre-
lation test was run to determine the relationship between
central corneal thickness and endothelial wound areas
induced by the freezing.
Figure 1: The transcorneal freezing machine attached to a cylinder of medical grade nitrous oxide (the cryogen), which comprises a main
console with a monitor screen that illustrates freeze time, cryogen levels, and readiness for freeze plus interchangeable probe tips and a
footswitch (not shown). Inset: the 3.4mm diameter concave probe tip manufactured from silver for high thermal conductivity.
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2.4. Scanning Electron Microscopy. To investigate the endo-
thelial damage morphologically, four treated corneas were
examined by scanning electron microscopy (SEM). Imme-
diately after excision, the corneas were ﬁxed in 2.5%
glutaraldehyde and 2% paraformaldehyde in 0.1M sodium
cacodylate buﬀer, pH 7.3, for at least 2 h. Samples were
then washed in PBS followed by the gradual dehydration
through a graded ethanol series (from 50% to 100% in
30min steps), after which the ethanol was replaced by
hexamethyldisilazane for 20min to minimize the shrinkage
of the specimens. After drying, the corneas were placed on
stubs (Agar Scientiﬁc, Stansted, UK) and sputter coated
with gold (Edwards S150 sputter coater, Edwards High
Vacuum Co. International, Wilmington, USA) to allow
imaging in a JEOL JSM 5600 scanning electron micro-
scope (JEOL Company, Tokyo, Japan) operating with a
beam acceleration voltage of 15.0 kV.
2.5. Transcorneal Freezing In Vivo. Three adult New Zealand
White rabbits were used to investigate corneal recovery after
transcorneal freezing. At all stages, animals were treated in
accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research, and the research was
approved by the IRB of Doshisha University. As reported
later, the 3.4mm concave cryoprobe was found to be the
most eﬀective in inducing endothelial damage in the porcine
eye in vitro, but owing to the thinner cornea of the rabbit, the
2.4mm concave cryoprobe was chosen for the in vivo trans-
corneal freezing experiments.
Under general anesthesia, a 2.4mm probe was applied to
the corneal surface of the rabbit eyes for a total of 5 sec. The
contralateral eye was used as a control. Transcorneal freezing
did not induce any severe general adverse eﬀects. After 24 h,
10 days, and 1 month of treatment, the anterior segment of
each eye was assessed by the use of a slit-lamp microscope
and the rabbits were then euthanized. Corneal thickness
was determined by the use of an ultrasound pachymeter
(SP-2000; Tomey, Nagoya, Japan), and the mean of eight
measured values was calculated. Intraocular pressure was
measured by the use of a Tonovet tonometer (292000;
KRUUSE, Langeskov, Denmark). Transmission electron
microscopy (TEM) was conducted, as described below, on
the corneas of the rabbits that were euthanized at 24h- and
1-month time points after transcorneal freezing.
2.6. Transmission Electron Microscopy. The rabbit corneas
were examined by TEM 24h and 1 month postfreeze was
conducted in Doshisha University, Japan. Brieﬂy, after ani-
mals were euthanized, corneas were excised at the limbus
and ﬁxed in 2.5% glutaraldehyde and 2% paraformaldehyde
in 0.1M Sörensen buﬀer (pH 7.2–7.4) overnight at 4°C.
Samples in fresh ﬁxative were then express shipped to the
UK. Full-thickness-dissected portions of the corneas were
then subjected to alcohol dehydration and resin inﬁltration,
after which they were embedded in epoxy resin (Araldyte
CY212 resin, TAAB Laboratories, England, UK). Ultrathin
sections were stained with uranyl acetate and lead citrate
and examined on a JEOL 1010 microscope operating at
80 kV (JEOL Company, Tokyo, Japan).
3. Results
3.1. In Vitro Transcorneal Freezing. Initial experiments into
the degree of endothelial damage caused by transcorneal
freezing induced by four diﬀerent types of cryoprobe
tip—that is, 1.8mm diameter/ﬂat proﬁle, 2.4mm diameter/
ﬂat proﬁle, 2.4mm diameter/concave proﬁle, and 3.4mm
diameter/concave proﬁle—revealed that the time of contact
with the corneal surface did not aﬀect the area of endothelial
damage, with freezing times of 3, 5, 9, and 13 sec tested (data
not shown). Based on this outcome, a freezing time of 3 sec
was chosen for all the in vitro experiments described herein.
It also became apparent during the initial investigations that
the probe tip had to be in contact with the corneal surface
before the foot switch was depressed to initiate cooling. If
the probe tip was cooled in air prior to being brought into
contact with the cornea, no appreciable endothelial damage
was seen; no matter how long, up to 15 sec, the probe
remained in contact with the cornea.
Light microscopy of the endothelial surfaces of the post-
freeze, trypan blue-stained corneas indicated the area of cell
damage caused by the four diﬀerent probes used in these
experiments. Representative images of 426 technical repli-
cates denoting the typical extent of endothelial damage are
shown in Figure 2, with examples of what were considered
to be successful or unsuccessful freeze injuries. A successful
freeze injury was deﬁned as one that resulted in a well-
delineated circular area of cell damage. An unsuccessful
freeze injury, on the other hand, was considered to have
occurred either when there was no evidence of any cell dam-
age or when the area of damage was irregular. Based on these
criteria, only 14 of 102 eyes (14%) treated with the 1.8mm
diameter/ﬂat proﬁle probe were judged to have been success-
fully wounded, whereas 78 of 108 (72%) treated with the
larger (i.e., 2.4mm diameter) ﬂat proﬁle probe contained suc-
cessful endothelial injuries. A similar number of the eyes
exhibited corneal endothelial freeze damage—that is, 76 eyes
of 108 (70%)—when the 2.4mm diameter cryoprobe with a
concave proﬁle was used. Our data clearly indicated, how-
ever, that the 3.4mm diameter/concave proﬁle cryoprobe
induced the most consistent endothelial damage with 90 eyes
of 108 (83%) being successfully wounded in a reproducible
manner (Table 1).
To quantify the extent of endothelial cell damage, we
used Image J to manually trace around each wound deemed
to have been successfully created (i.e., n = 258 of 426 techni-
cal replicates). The area of each wound was calculated, which,
unsurprisingly, disclosed that larger probe tips led to more
extensive endothelial damage (Table 1). All of the 426
corneas examined were subjected to multiple pachymetry
measurements immediately prior to transcorneal freezing.
This revealed that the average corneal thickness was 649μm
(±61μm SD), which is a fair representative value for corneal
edema in humans with endothelial dysfunction [31, 32].
Moreover, when the corneal thickness of the individual cor-
neas was taken into account, a statistical Spearman’s rank
order correlation test identiﬁed that there was a weak
relationship between central corneal thickness and endothe-
lial damage when treated with the smallest and largest probes
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1.8 mm
at 
595 휇m ± 6.6 556 휇m ± 3.7
(a) (b)
2.4 mm
at
496 휇m ± 15.7 483 휇m ± 4.8
(c) (d)
2.4 mm
concave 
562 휇m ± 6.4 533 휇m ± 1.8
(e) (f)
3.4 mm
concave 
651 휇m ± 4.6 628 휇m ± 1.8
(g) (h)
Figure 2: Representative images of corneal endothelial freeze injury on the pig eyes ex vivo induced by 3 sec freeze with four diﬀerent
cryoprobe tips and assessed by trypan blue staining. The thickness of each cornea is indicated on each panel (±SD) based on eight
pachymetry readings. The area of cell damage is seen via the blue stain, and successful and non/less successful freeze injuries are shown in
the left and right columns, respectively. Freezing with the 1.8mm diameter/ﬂat proﬁle probe only rarely resulted in a reproducible wound
(a and b). Endothelial freeze injury was more reliably achieved with 2.4mm diameter probe tips with ﬂat or concave proﬁles (c–f), but the
optimal result and best consistency was achieved using the 3.4mm diameter/concave proﬁle cryoprobe (g and h). Scale bar, 3mm. See
Table 1 also.
Table 1: Data summary of transcorneal freezing for 3 sec on porcine eyes.
Probe tip (mm)/proﬁle
Number
of eyes
Number of eyes with
successful freeze (%)
Mean/SD damaged
area (mm2)
Mean diameter (mm)
Mean/SD
corneal
thickness (nm)
1.8/ﬂat 102 14 (14) 0.79/0.4 1.0 642/64
2.4/ﬂat 108 78 (72) 2.12/1.0 1.6 650/71
2.4/concave 108 76 (70) 2.29/1.0 1.6 645/87
3.4/concave 108 90 (83) 6.91/1.9 2.9 654/59
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure 3: SEM of the endothelium of transcorneally frozen pig corneas. (a) An untreated pig cornea with cell boarders in white showing a
characteristic hexagonal mosaic. The outline if the cell nucleus is evident as a slightly lighter area within each cell. Scale bar, 10μm. (b) A
representative image taken at the same magniﬁcation of the freeze-damaged area after treatment with a 2.4mm diameter/concave proﬁle
tip, illustrating severe damage to endothelial cells by freezing. Scale bar, 10 μm. (c and d) Lower magniﬁcation images of endothelial
freeze-injured wounds showing circular areas of endothelial cell damage including some endothelial debridement, exposing Descemet’s
membrane (c): 2.4mm diameter/concave proﬁle cryoprobe (scale bar, 200μm); (d): 3.4mm diameter/concave proﬁle cryoprobe (scale bar,
500μm). As expected, the larger probe induces more widespread damage (see Table 1 also). (e–h) Transition zones between unfrozen
endothelial cells and those that were destroyed by freeze injury are often sharp (e) and (g); same area but diﬀerent magniﬁcation (scale
bars,10μm, apart from (g) which is 50 μm).
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(1.8mm diameter (r = –0 208, n = 102, p = 0 408) and
3.4mm diameter (r = –0 258, n = 108, p = 0 007) but a
stronger relationship using the 2.4mm diameter probe tips
with concave and ﬂat proﬁles (r = –0 433, n = 108,
p < 0 001; 2.4mm (r = –0 466, n = 108, p < 0 001, respec-
tively) (Table 1).
To provide higher resolution information as to the status
of the cells after freeze injury in the in vitro pig eye model, we
conducted a series of SEM studies (Figure 3). This indicated
that the corneal endothelial monolayer was severely
disrupted in the central portion of the cornea beneath the site
of the cryoprobe injury. Injured cells tended to become
damaged and/or disassociated from each other, whereas
noninjured cells adjacent to the area of damage exhibited
classic hexagonal endothelial cell morphology. Interest-
ingly, there appeared to be two transition zones between
healthy nonfrozen cells and the more centrally damaged
ones. The immediate transition at the inner edge of the
morphologically normal cells was fairly abrupt; and in
some cases, this was on a μm scale (Figures 3(e), 3(f),
and 3(g)). More centrally, there was evidence of cellular
dissociation (Figure 3(e)) and also total removal of large
areas of frozen endothelial cells, exposing a bare Desce-
met’s membrane (Figures 3(d) and 3(h)).
To investigate endothelial healing after transcorneal
freeze, a smallnumberof rabbit corneaswere studied.For these
investigations, a 2.4mm diameter/concave proﬁle cryoprobe
was used rather than the 3.4mm concave one owing to the
relative thinness (approximately 350–400μm) of the rabbit
cornea compared to that of the pig (approximately 660μm
[29, 30]). This revealed that one day after a 3 sec surface freeze,
the rabbit cornea had become signiﬁcantly edematous, with its
thickness approximately twice the normal value (Figure 4(a)).
The central corneal thickness returned to normal values by
day 7, and this was maintained up to one month post-
freeze (Figure 4(c)). Slit-lamp images showed some evi-
dence of corneal haze at the level of the posterior stroma
or Descemet’s membrane at 10 days and 1 month
(Figures 4(b) and 4(c), resp.).
TEM examinations of rabbit corneas 24 hrs after freeze
indicated that the corneal epithelium peripheral to the
wound area was structurally normal, with typical epithelial
stratiﬁcation, cell-cell contact and surface microvilli
(Figure 5(a)). As expected, the corneal epithelium was
severely damaged in the central freeze-injured region of the
cornea, with considerable cellular vacuolation and mem-
brane destruction (Figure 5(b)). However, it was clear that
the epithelial basement membrane remained intact, which
presumably is important to aid subsequent epithelial resurfa-
cing of the wound area. In the deep stroma, increased
collagen ﬁbril spacing accompanied by disorder in the ﬁbril
arrangement was sometimes observed focally 24 hrs post-
freeze (Figure 5(c)), but this had been resolved by the 1-
month timepoint at which time the stromal architecture
appeared normal throughout the cornea (Figure 5(d)). These
structural matrix changes likely contribute to the increased
corneal thickness and opacity seen at 24 hrs (Figure 4(a)).
Just as with the corneal epithelium, the corneal endothe-
lium in the periphery of the cornea away from the region of
the tissue under the surface wound zone remained unaﬀected
CCT 769 휇m
IOP 9 mmHg
CCT 383 휇m
IOP 11 mmHg
PostfreezePrefreeze
24 h
CCT 385 휇m
IOP 17 mmHg
CCT 378 휇m
IOP 9 mmHg
10 days
(a) (b)
CCT 366 휇m
IOP 8 mmHg
CCT 389 휇m
IOP 11 mmHg
1 month
(c)
Figure 4: Eﬀects of a 3 sec freeze on the rabbit cornea in vivo using the 2.4mm diameter/concave proﬁle cryoprobe tip. (a) 24 hrs after freeze,
central corneal thickness (CCT) is increased considerably (769 μm) compared to that before freeze (383 μm), and the cornea is hazy,
indicative of corneal endothelial damage, as well as epithelial and stromal cell damage. (b) 10 days after a freeze injury (in a diﬀerent
animal), CCT was at normal levels. (c) This was the case also, 1 month after treatment. (b and c) Some corneal haziness at the level of the
posterior stroma or Descemet’s membrane is evident at 10 days and 1 month.
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24 hrs after transcorneal freeze of the central rabbit cornea
(Figure 6(a)). The endothelium more centrally, however,
began to exhibit clear signs of damage (Figure 6(b)). The
central endothelium was often fully debrided with a bare
Descemet’s membrane that showed no apparent structural
changes (Figure 6(c)). One month after freeze, the central
corneal endothelium had reattained its normal character,
although occasionally ﬁbrous tissue deposition between
Descemet’s membrane and the recovered endothelium was
observed (Figure 6(d)), which perhaps contributes to the
deep stromal haze seen at this time (Figure 4(c)).
4. Discussion
A number of investigative surgical procedures, which utilize
the selective ROCK inhibitor, Y27632, to combat FECD
and bullous keratopathy are under investigation, including
cell-injection therapy [10–14]. However, one alternative
approach for FECD, especially in its early stage, involves
freezing the central cornea using a cold probe to damage
corneal endothelial cells beneath the surface contact area; this
is then followed by the short-term delivery, for one week, of
Y27632 in eye drop formulation [10–12]. In these surgeries,
freezing was achieved by touching the corneal surface with
a stainless steel rod, which had been immersed in liquid
nitrogen. An arbitrary freezing time of 15 sec was chosen
for these experiments, along with a 2mm diameter for the
steel rod. Encouragingly, the outcomes of these surgeries
showed some promise, especially if the extent of the corneal
endothelial dysfunction was not widespread, but if the
approach is to be adopted more widely by the ophthalmic
community, the corneal freeze would probably need to be
achieved in a more reliable manner and with more knowl-
edge of the nature and extent of the freeze damage.
Historically, and up to the present day, corneal freezing
has been carried out by a variety of methods, most of which
use it to induce an experimental injury for research into
corneal wound healing [15–17, 28]. Freezing studies tend to
employ either a brass rod or dowel, which had been
immersed in liquid nitrogen [17–21] or similarly cooled steel
ones [22, 23]. Retinal cryoprobes have also been used in
investigational studies of transcorneal freezing [24, 33]. Here,
we report the design and manufacture of a corneal cryoprobe
that uses circulating nitrous oxide as a cryogen and report the
type of freeze damage it induces.
Typically, the tips of cryoprobes that use high-pressure
gas as a cryogen are made of stainless steel owing to the need
to contain high-pressure gas safely. In our design, however,
St
BM
Ep
1 휇m
BM
Ep
St1 휇m
(a) (b)
0.5 휇m
St
(c) (d)
Figure 5: TEM of the corneal epithelium (Ep), epithelial basement membrane (BM), and stroma (St) following a 3 sec transcorneal freeze
injury using a 2.4mm diameter/concave proﬁle cryoprobe on rabbit cornea in vivo. (a) The peripheral epithelium away from the wound
zone, 24 hrs after the cryoprobe was applied and appeared morphologically normal. Arrowheads indicate microvilli on apical surface of
epithelial cells. (b) Intact basement membrane is observed in the central freeze-injured area 24 hrs postfreeze. (c) After 24 hrs freeze injury,
occasional focal regions of stromal matrix disruption were evident in the cornea, manifesting as tissue regions with increased spacing
between collagen ﬁbrils. (d) One month after the freezing, throughout the cornea, the spacing between collagen ﬁbril appeared normal.
Scale bars, 1 μm (a and b) and 0.5μm (c and d).
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the use of stainless steel would have resulted in a freeze that
started in the center of the tip and thereafter spread, albeit
quickly, to its outer circumference at a speed which relies
on the thermal conductivity of the metal. To achieve a more
uniform cooling across the probe tip, we manufactured a
cryoprobe tip out of silver, which has a higher thermal con-
ductivity than that of steel. The beneﬁt of this design feature
is that the diameter of the freeze in the cornea is decoupled
from the depth of the freeze. Cooling in this design is based
on the expansion and internal recycling of nitrous oxide
inside the cryoprobe tip. At the point of its transition
from liquid to gas, nitrous oxide exists at a temperature
of −88.5°C, and this transition, which occurs inside our
probe tip, of course, rapidly cools it. Owing to thermal
conductivity within the whole probe and thermal loss at
ambient room temperature, an equilibrium is reached,
which in our design means that the temperature at the
outer surface of the probe tip reaches −50°C.
The response of a cell to freezing is explained by
Fraunfelder in his comprehensive review of corneal cryo-
therapy, the main mechanisms of cell damage being a
piercing of the cell membrane by ice crystals or the
creation of a sizeable osmotic imbalance between the
inside and outside of the cell because of the removal of
liquid water into the ice crystals [34]. Armitage also
describes, from the other side of the coin, how careful
freezing using time-mediated freeze-thaw protocols accom-
panied by the use of cryoprotectants can lead to cell sur-
vival [35]. The freezing we achieve here can probably be
thought of as being fairly conservative in terms of the rate
of endothelial cooling, but our current observations clearly
indicate that suﬃcient levels of endothelial damage are
achieved after a single freeze treatment. Experiments that
applied additional treatments to the same surface location
did not enhance the extent of the freeze injury (data not
shown). We also found that if the foot switch was
depressed to initiate cooling of the probe tip before it
was brought into contact with the corneal surface, then
no appreciable endothelial freeze damage was seen, even
if the cryoprobe was kept in contact with the cornea for
periods up to 15 sec. It is not immediately clear why this
is the case, but perhaps, frosting of the probe tip when it
is cooled in the moist air could contribute to this. This
likely lack of frosting also might help facilitate the easy
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Figure 6: TEM of corneal epithelium following a 3 sec transcorneal freeze injury using a 2.4mm diameter/concave proﬁle cryoprobe on the
rabbit cornea in vivo. (a) An endothelial cell (Endo) at 24 hrs postfreeze in a region peripheral to the freeze-injured area appeared
morphologically normal, with normal organelles and nucleus (n). It adhered to Descemet’s membrane (DM). (b) Closer to the region
below the cryoprobe surface application, there were clear signs of cell damage including the destruction of the cell membrane, while even
more centrally, (c) the cell damage was more extreme revealing a bare Descemet’s membrane, consistent with the SEM analysis (Figure 3).
(d) One month after the transcorneal freezing was performed, the central region of the inner cornea contained fairly normal endothelial
cells that were sometimes accompanied by extracellular matrix material (white arrowheads) in the area posterior to Descemet’s
membrane. Scale bars, 2 μm.
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release of the probe tip from the corneal surface after the
foot switch is released, which we found to happen within a
second or two of the cryogen circulation being suspended.
In the experiments described here, the central corneal
epithelium was destroyed by the application of the cryo-
probe, as we would expect. But, it is of potential importance
that the corneal epithelial basement membrane remains
intact as seen by TEM. The lack of epithelial basement mem-
brane damage will presumably aid the epithelial resurfacing
of the debrided epithelial area. Fibril arrangement changes
are also apparent focally in the stromal matrix after the
in vivo rabbit freeze injury, but these are transient, and the
increased collagen ﬁbril separation and disorganization
which are seen 24 hrs after the treatment subsequently
decrease as corneal thickness reduces. The obvious conclu-
sion is that the recovering endothelium is mostly responsi-
ble. Of course, the in vivo healing studies reported here do
not reﬂect the situation in the human cornea because of
the diﬀerent behavior of the endothelial cells and their
limited replicative ability in humans. TEM also discloses
the presence of ﬁbrotic extracellular matrix tissue in the
region of Descemet’s membrane one month after freeze
injury (Figure 6(d)). This might contribute to the deep
stromal haze seen at this time, although a potential contri-
bution to light scatter by freeze-damaged keratocytes can-
not be discounted.
As mentioned, the use of ROCK inhibitors has aided the
recovery of the corneal endothelium in situations where
diseased corneal endothelial cells have been scraped away
surgically [13] or frozen with a cooled steel rod applied to
the corneal surface [10–12]. A report by Balachandran et al.
[36] and Shah and associates also suggests that corneal endo-
thelial cells can repopulate in FECD patients after damage
alone [37–39]. The data presented here show that endothelial
cells can be functionally damaged and/or removed by the
application of a cryogenic cold probe and that this can be
done in a targeted and reproducible manner with cell damage
restricted to the area below the surface contact. Of course, the
transcorneal freezing technique is unlikely to induce any
signiﬁcant change to the guttae which exist in FECD and
their continued presence will conceivably hinder the refor-
mation of a normal endothelial layer. Nevertheless, cell
damage can be achieved through use of a silver 3.4mm
diameter cryoprobe with a concave proﬁle, which was
discovered to be the optimal design of the cryoprobes
tested in the experiments described here. It thus has the
potential to rapidly and reliably induce damage to the
human corneal endothelium via transcorneal freezing,
leaving the epithelial basement membrane intact. This
has the potential to be used prior to the application of
ROCK inhibitors to the eye in the form of eye drops
[10–12] or as slow-release chemicals from thin ﬁlms [40]
to aid the recovery of corneal endothelial function.
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